Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,602 public trials 545 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Active, Not Recruiting

A Study of Real Life Treatment for Multiple Myeloma (MM)

NCT04985643

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Altai Regional Clinical Hospital Barnaul, Altayskiy Kray, Russia
  • Kaluga Regional Clinical Hospital Kaluga, Central Federal District, Russia
  • Smolensk Clinical Hospital of Russian Railways-Medicine Smolensk, Central Federal District, Russia
  • City Clinical Hospital No. 1 named after prof. S.I.Sergeev Khabarovsk, Far Eastern Federal District, Russia
View all 24 locations
View Trial Details
Active, Not Recruiting

Loncastuximab Tesirine in WM

NCT05190705

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Fred Hutch Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)

NCT05354557

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent and Followup) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow-Up only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow up) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Consent and Follow up) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone

NCT03104842

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Vivantes Am Urban Berlin, Germany
  • Campus Benjamin Franklin Charite Berlin Berlin, Germany
  • Vivantes Klinikum Neukölln Berlin, Germany
  • Städt. Kliniken Bielefeld Klinikum Mitte Bielefeld, Germany
View all 17 locations
View Trial Details

Related conditions